Both pretreatment prostate-specific antigen level and posttreatment biochemical failure are independent predictors of overall survival after radiotherapy for prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 60, Issue 4, 2004, Pages 1082-1087

  Williams, Scott G ^a,d   Duchesne, Gillian M ^b   Millar, Jeremy L ^a   Pratt, Gary R ^c  

^a William Buckland Radiotherapy Centre   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d ALFRED HOSPITAL   (Australia)

Author keywords

Prostate specific antigen; Radiotherapy; Survival

Indexed keywords

BIOCHEMISTRY; BIOPSY; RADIOTHERAPY; RISK ASSESSMENT; STATISTICAL METHODS; TUMORS;

BIOCHEMICAL FAILURE; CLINICAL STAGE; MONOTHERAPY; PROSTATE-SPECIFIC ANTIGEN (PSA);

ANTIGENS;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BEAM THERAPY; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHRONOLOGY; DATA ANALYSIS; DISEASE MARKER; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD; MONOTHERAPY; MULTIVARIATE ANALYSIS; PATIENT INFORMATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CARCINOMA; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS;

EID: 7444221844     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.04.048     Document Type: Article

References (26)

1. Horwitz E.M., Vicini F.A., Ziaja E.L., et al. The correlation between the ASTRO Consensus Panel definition of biochemical failure and clinical outcome for patients with prostate cancer treated with external beam irradiation. Int J Radiat Oncol Biol Phys. 41:1998;267-272
2. Taylor J.M., Griffith K.A., Sandler H.M. Definitions of biochemical failure in prostate cancer following radiation therapy. Int J Radiat Oncol Biol Phys. 50:2001;1212-1219
3. Kupelian P.A., Buchsbaum J.C., Patel C., et al. Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era. Int J Radiat Oncol Biol Phys. 52:2002;704-711
4. Sandler H.M., Dunn R.L., McLaughlin P.W., et al. Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy. Int J Radiat Oncol Biol Phys. 48:2000;629-633
5. Pollack A., Hanlon A.L., Movsas B., et al. Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys. 57:2003;19-23
6. Kestin L.L., Vicini F.A., Martinez A.A. Practical application of biochemical failure definitions What to do and when to do it. Int J Radiat Oncol Biol Phys. 53:2002;304-315
7. Jhaveri F.M., Zippe C.D., Klein E.A., et al. Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer 10-year results. Urology. 54:1999;884-890
8. Kwan W., Pickles T. In regard to Kupelian, et al. Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era - IJROBP 2002;52:704-711. Int J Radiat Oncol Biol Phys. 54:2002;1577-1579
9. Fisher B., Anderson S., Fisher E.R., et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet. 338:1991;327-331
10. Sobin L.H., Wittekind C. International Union against Cancer. TNM classification of malignant tumours. 5th ed. :1997;Wiley & Sons, New York
11. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statement Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys. 37:1997;1035-1041
12. Cox D.R., Oakes D. Analysis of survival data. 1984;Chapman and Hall, London
13. SPSS Inc. SPSS advanced statistics, version 11.5. Chicago: SPSS Inc.; 2002
14. Roach M. III, Weinberg V., McLaughlin P.W., et al. Serum prostate-specific antigen and survival after external beam radiotherapy for carcinoma of the prostate. Urology. 61:2003;730-735
15. Shipley W.U., Thames H.D., Sandler H.M., et al. Radiation therapy for clinically localized prostate cancer A multi-institutional pooled analysis. JAMA. 281:1999;1598-1604
16. Roach M., Lu J., Pilepich M.V., et al. Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on Radiation Therapy Oncology Group clinical trials. Int J Radiat Oncol Biol Phys. 47:2000;609-615
17. Partin A.W., Kattan M.W., Subong E.N., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer A multi-institutional update. JAMA. 277:1997;1445-1451
18. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response Results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 53:2002;1097-1105
19. Kupelian P.A., Mohan D.S., Lyons J., et al. Higher than standard radiation doses (> or =72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys. 46:2000;567-574
20. Bolla M., Collette L., Blank L., et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study) A phase III randomised trial. Lancet. 360:2002;103-106
21. Cheung R., Tucker S.L., Dong L., et al. Dose-response for biochemical control among high-risk prostate cancer patients after external beam radiotherapy. Int J Radiat Oncol Biol Phys. 56:2003;1234-1240
22. Hanks G.E., Hanlon A.L., Pinover W.H., et al. Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy. Cancer J Sci Am. 5:1999;152-158
23. Post P.N., Hansen B.E., Kil P.J., et al. The independent prognostic value of comorbidity among men aged <75 years with localized prostate cancer A population-based study. BJU Int. 87:2001;821-826
24. Gooley T.A., Leisenring W., Crowley J., et al. Estimation of failure probabilities in the presence of competing risks New representations of old estimators. Stat Med. 18:1999;695-706
25. Gelman R., Gelber R., Henderson I.C., et al. Improved methodology for analyzing local and distant recurrence. J Clin Oncol. 8:1990;548-555
26. Vicini F.A., Kestin L.L., Martinez A.A. The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys. 45:1999;553-561